Transdiagnostic Group Therapy (GBAT) for Autistic Adults With Personalized Therapeutics

Completed · Not applicable

Conditions studied: GBAT+Individual, GBAT+Engagement Booster, GBAT+Both

In brief

The purpose of this study is to build upon an earlier study that evaluated the use of a 10-week transdiagnostic Group Behavioral Activation Therapy (GBAT), a telehealth delivered intervention, as a cost effective and accessible way to treat symptoms of anxiety and depression in autistic adults. The current study will pilot and compare relative feasibility, acceptability, and preliminary efficacy of three adapted GBAT groups and a Watchful Waiting (WW) group. The three groups include GBAT+Individual (GBAT+I; individual sessions to supplement the 10 group sessions), GBAT+Engagement Booster (GBAT+E; supplemental materials), and GBAT+Both (GBAT+IE individual sessions and supplemental materials).

Key facts

Study ID

NCT05512221

Run by

Rutgers, The State University of New Jersey

People needed

33

Starts

2022-09-23

Expected to finish

2024-07-01

Last updated by the study team

2024-10-29

Who can join

Age: 18 and older, up to 40. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Live in New Jersey or New York
• Be 18-40 years old
• Have a confirmed diagnosis of Autism Spectrum Disorders (ASD).
• Have access to a device (e.g., computer with a webcam or smartphone) in order to complete online surveys and participate in videoconference sessions
• WRAT Reading Comprehension grade equivalent 6th grade or higher
• Receive a best-estimate diagnosis of an anxiety or mood disorder (Generalized Anxiety Disorder, Social Anxiety Disorder, Specific Phobia, Panic Disorder, Agoraphobia, Major Depressive Disorder, Unspecified Depression, Persistent Depressive Disorder).
• Be interested in participating in an online telehealth treatment group to address their difficulties in the aforementioned areas
• Approximately 60% of our sample will be White, Non-Hispanic; approximately 40% of our sample will be female-identifying and 40% will be male-identifying

You may not qualify if…

• Are younger than 18 years old, or older than 40 years old
• Do not have an ASD diagnosis
• Have WRAT Reading Comprehension below 6th grade level
• Are unable to understand English fluently
• Have a principal DSM-5 disorder other than one of the above listed anxiety or depression disorders, have received a diagnosis of Intellectual Disability, schizophrenia, or bipolar disorder or demonstrate suicidal ideation or intent severe enough to require current hospitalization, or who have attempted suicide in the past 3 months.
• Are currently enrolled in another behavioral therapy or psychotherapy targeting depression, anxiety or anger.
• Are experiencing suicidal ideation that requires current hospitalization.
• The PI's best clinical judgment that it would not be in the adult's best interest to be enrolled (e.g., due to factors that may affect their engagement or comfort in the group).

Where it is running

• Rutgers University — Piscataway, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.